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PRM197
DeveloPMent of a MeasuRe to assess seveRity of MPs ii: the Disease 
seveRity scoRe
Vernon MK1, Raluy-Callado M1, Trundell D2, Wiklund I1, Pulles T3, Whiteman DA4
1Evidera, London, UK, 2Evidera, Inc., London, UK, 3Shire, Zug, Switzerland, 4Shire, Lexington, MA, 
USA
Objectives: To date, no mucopolysaccharidosis type II (MPS II) measure capturing 
disease severity exists other than classifying patients with and without cognitive 
impairment. This study aimed to develop a clinician-reported outcome (ClinRO) 
to assess somatic and central nervous system (CNS) severity in patients with MPS 
II. MethOds: Following a literature review to identify key indicators of MPS II sever-
ity and interviews with pediatric specialists, two interactive video conferences with 
clinicians from the Hunter Outcome Survey (HOS) working groups were conducted 
to review the draft instrument and discuss definitions and descriptions of observ-
able signs and symptoms and objective clinical parameters. Patient vignettes based 
on hypothetical cases with different ranges of severity were developed to evalu-
ate inter-and intra-rater reliability. Further refinement of items and descriptions 
were discussed in additional expert panels to obtain consensus on content validity, 
including wording and importance of individual items. Results: The current ver-
sion of the Disease Severity Score (DSS) comprises two components, somatic and 
CNS, with 17 items covering 11 domains altogether. The somatic component (11 
items) includes respiratory, hearing, cardiac, neurology, and orthopaedic domains. 
The CNS component (6 items) covers cognition, language & communication, activity 
level & focus, toileting, sleeping disorder, and seizures. Most items used a severity 
rating (normal, mild, moderate, and severe) accompanied by a clinical description; 
some items in the Somatic component also contain objective clinical parameters. 
Intra-rater reliability was demonstrated for all items (κ appa> 0.80). cOnclusiOns: 
A novel and innovative approach was used in the development of this ClinRO with 
the consensus of experts in MPS II. The DSS is intended to assess disease severity 
using observable signs and symptoms, track somatic and CNS disease severity and 
progression over time and to compare severity of MPS II across centers interna-
tionally. A scoring algorithm and assessments of validity and responsiveness are 
currently being developed.
PRM198
cost analysis stuDy of oRal anti-Diabetic DRugs available in inDian 
govt geneRic (Jan aushaDhi,JeevanDhaRa ) DRugs anD bRanD DRugs 
MaRket in RuRal / uRban aRea of guntuR, anDhRaPRaDesh, inDia
Nallani VR
Chalapathi Institute Of Pharmaceutical Sciences, Guntur, India
Objectives: To analyze the cost variation of oral anti-diabetics of different generic 
drugs sold at Jan Avushadhi and jeevanadhara and Retail pharmacy available brand 
names of single compound and combination compounds to evaluate the differ-
ence in cost , percentage variation of cost. MethOds: Cost of single and combina-
tion compound drugs manufactured by different companies, in the same strength, 
number and dosage form was obtained from Current Index of Medical Specialties” 
July-October 2014 and jan avushdhi,jeevandharaa drugs were compared upto 
February -2015. Results: In Single compound drug usage, among sulfonylurea 
group of drugs, Glibenclamide (2 mg) shows maximum price variation of 1980%, 
while Glipizide (10mg) shows variation of 55.61%. In Biguanides & Thizolidinediones 
groups Of drugs Metformin (1000 mg) show Maximum price variation is 125.37%, 
Metformin (500 mg) leat variation is 30 % and Piglitazone (30mg) show Maxmum 
variation 3060.97% and least variation Pioglitazoe (15 mg) is 3275 respectively. . 
In α -glucosidases inhibitor group of drugs,Miglitol shows maximum price varia-
tion of 135.50 % and Minimum variation is 41.93 %. Meglitinides group of drugs. 
In this group, Rapaglinide (0.5 mg) shows Maximum price variation of 79.25 % and 
Minimum variation is 60 % respectively. Dipeptidyl peptidase IV inhibitors (e.g., 
Sitagliptin), group Sitagliptin (100 mg) shows Maximum price variation of 902.3 %. 
In combination therapiesGlibenclamide + Metformin (5 mg+ 500 mg) combination 
shows the maximum variation up to 2400 % and Glipizide + Metformin (2.5mg + 
250mg) showed minimum price variation of 28.60% respectively. cOnclusiOns: 
Study has concluded that the cost variation increases when competition between 
the manufacturing companies and generic companies. cost which company provid-
ing less cost and whether these drugs are available janavushadhi or jeevandhara or 
generic pharmacy shops. So that we can minimize the cost burden on consumers.
PRM199
MeasuReMent invaRiance of the Whoqol-olD MoDule acRoss 
DiffeRent DeMogRaPhic gRouPs in taiWan’s elDeRly PeoPle
Hsieh P, Yao G
National Taiwan University, Taipei, Taiwan
Objectives: The purpose of this study is to examine the measurement invari-
ance of the WHOQOL-OLD Module across different demographic groups in Taiwan’s 
elderly people. By testing the differential item functioning (DIF), the presence of DIF 
indicates measurement variance. In other words, item score of measurement scale 
is dependent on some irrelevant characteristics. If this condition is observed the 
interpretation of items would be confounded. MethOds: A total sample 524 par-
ticipants involved in this study, but only 503 participants (96%) completed the whole 
questionnaire. The questionnaire included the WHOQOL-OLD and the demographic 
characteristics (age, gender, and education). Multiple-indicator multiple-cause 
latent variable (MIMIC) model was used to explore the relationship between the 
latent factors and demographic variables. Data was analyzed by using the Mplus7.0 
and SAS9.4 software. Results: Multiple-indicator multiple-cause latent variable 
model showed significant differences were observed on sensory abilities, death and 
dying for different age and education and on social participation only for different 
education. However, the significant differences can be eliminated when adjusting 
for DIF on item1 and item18, respectively, on sensory abilities and social participa-
tion. cOnclusiOns: The result implies that age and education should be controlled 
when comparing sensory abilities, death and dying and social participation facets. 
Objectives: To define the term ‘usually’ in order to ascertain potential pitfalls in 
its translation in any future target language. MethOds: This posed a particular 
issue in translation of the ADSC (Activities of Daily Living Inventory) in which the 
term appears 28 times in the form of either ‘usual’ or ‘usually’. Discussion with 
the client confirmed the desired and contextual meaning of the term for this 
instrument, with additional guidance from clinicians, and the issue was discussed 
extensively with linguists for all 31 languages in this particular study. Results: 
After in-depth discussion between ICON Language Services and the client, it was 
agreed that a more specific definition of ‘usually’ should be checked and applied 
to the translations so as to avoid risk in incorrect data collection and poten-
tially causing offence to the target population. Concern was raised that the term 
could be mistaken for ‘normally’, which could lead to specifying what is ‘normal’ 
vs ‘abnormal’, i.e. making a judgement about the behaviour of the subject. We 
ensured that the term ‘usually’ was not translated as ‘normally’, did not imply 
‘normal’ vs ‘abnormal’ behaviour and rendered the concept of frequency present 
in the source term ‘usual’. cOnclusiOns: In this project, it was vital that the term 
‘usually’ should carry a wholly descriptive value, meaning that the phenomenon 
in question occurs with high frequency or by habit/custom. This should not be 
confused with the concept ‘normally’, which can carry a prescriptive connotation 
implying an underlying rule/order. To avoid any ambiguous or incorrect transla-
tion of the word ‘usually’, it is strongly advised that this be clearly defined from 
the start and checked throughout the linguistic validation process. Discussion 
between the client and linguistic staff reveals the importance of close collabora-
tion in resolving terminology issues and improving data integrity through the 
conceptual equivalence of translations.
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MigRation of the fatigue syMPtoMs anD iMPacts questionnaiRe–
RelaPsing MultiPle scleRosis (fsiq-RMstM) fRoM PaPeR to an 
electRonic DiaRy foRMat
Eremenco S1, Shaffer S1, Schüler R2
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Objectives: The FSIQ-RMS™ is the first patient-reported outcome (PRO) measure 
of fatigue in RMS developed according to the 2009 FDA PRO guidance.1 A qualita-
tive study was conducted to provide evidence of adequacy after adapting the FSIQ-
RMS™ from paper to an electronic handheld device (eDiary). MethOds: Migration 
of the FSIQ-RMS™ to a BLU Life Play® Android™ smartphone involved modifying the 
instructions and landscape formatting with one item per screen. The FSIQ-RMS™ 
was administered to adult RMS patients at 2 US sites in a cross-sectional study. After 
training on the eDiary, each participant completed paper and electronic versions of 
the FSIQ-RMS™ in randomized order, then a device-usability questionnaire followed 
by one-on-one semi-structured cognitive interviews to assess comprehension of the 
FSIQ-RMS™, comparison between paper and electronic platforms, and usability of 
the eDiary. Results: The migration study included 10 RMS patients (mean age 42 
[range 27–54] years; 70% female), 8 with relapsing-remitting MS and 2 with relapsing 
secondary-progressive MS; mean±SD Expanded Disability Status Scale score 3.2±1.9. 
All participants understood and were able to view the FSIQ-RMS™ instructions, ques-
tions and response options, were able to answer the questions, and reported that the 
eDiary was easy to use. Based on participant comments, examples were added to one 
item to clarify the intended meaning. Discrepancies in response between formats 
were found, but most were not attributed to the device. Many participants (7/10, 70%) 
spontaneously reported preferring the eDiary to the paper format. Three participants 
suggested increasing the touch-sensitivity of the “Next” button; 5 suggested that they 
would have preferred a larger device (n= 3) and/or font size (n= 4). cOnclusiOns: 
Results confirmed the conceptual equivalence of the FSIQ-RMS™ eDiary to the paper 
version and its appropriateness for use with RMS patients. Further validation of the 
FSIQ-RMS™ will be conducted in a Phase III RMS trial. 1Value Health 2015;18(3):A26.
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MonitoReD cognitive DebRiefing inteRvieWs: a case stuDy
Talbert M1, Cole JC2, Brandt B3, McKown S1, Gawlicki M3
1Corporate Translations Inc, Chicago, IL, USA, 2PPD, San Diego, CA, USA, 3Corporate Translations 
Inc, East Hartford, CT, USA
Objectives: This study sought to determine the benefits to sponsor, developer, 
and translation provider of monitored cognitive debriefing interviews with patient 
questionnaires. Monitored cognitive debriefing (CD) was theorized to be particularly 
suitable for newly-developed questionnaires with minimal or no previous linguistic 
validation (LV), and for adapted questionnaires (i.e., a disease-specific instrument 
adapted to a new disease). MethOds: Thirty (30) CD interviews were carried out on 
a newly-developed patient instrument in six languages. Of those, sixteen (16) inter-
views were monitored by the sponsor. All languages were selected by the sponsor and 
a percentage of those interviews were monitored, the first languages to undergo LV. 
The translation provider recruited patients, provided interpreters, secured facilities 
with two-way mirrors and audio-visual recording capabilities, and performed the 
interviews. The monitor noted any sub-threshold issues that were outside of typical 
LV data capture rubric. Upon noting such issues in more than one country, the test 
authors would convene a meeting to consider if the PRO linguistic validation protocol 
or PRO source instrument required revision. Results: The monitor suggested follow-
up questions as needed during the CD interviews, tailoring the process to target spe-
cific dimensions of the PRO. Issues were tracked across languages by the monitor, and 
the interviewer asked subjects for their preference for alternative translations, when 
suggested by the monitor. Compared to those interviews which were unmonitored, 
on average, subjects made more comments overall, and more comments leading to a 
translation revision. cOnclusiOns: Monitored interviews are beneficial for the vali-
dation of newly-developed or adapted instruments. This augmentation to CD provides 
a means of vendor management and early identification of issues during LV that are 
outside of the typical data capture rubric. The process enables the sponsor to suggest 
follow-up questions or modifications on-site, thus correcting issues preemptively that 
may negatively impact understanding and subsequent data pooling.
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was non-significant for one health state. Kolmogorov Smirnov tests supported the 
results (two significant at 1%, one at 5% and one at 10%, the remaining being non-
significant. cOnclusiOns: The first question in TTO questionnaires may induce 
anchoring in the final valuations.
PRM203
PeRfoRMance scoRe extRaction fRoM Panel Data foR Multi-cRiteRia 
Decision analysis (McDa) using a RegRession-baseD aPPRoach
Verbeek NA1, Tsiachristas A2, Franken M1, Koopmanschap MA1, Rutten-van Mölken MP1
1Erasmus University Rotterdam, Rotterdam, The Netherlands, 2University of Oxford, Oxford, UK
Objectives: Key to effectively implementing MCDA is to ensure the performance 
matrix offers a valid comparison across alternatives. We propose to bring econo-
metric methods into the field of MCDA by estimating performance scores from 
patient-level panel data while matching on observable patient characteristics 
between different treatment alternatives. The aim of this study is to demonstrate 
the application of these methods to a case study using outcomes of disease man-
agement programs for Cardio-Vascular Risk Management (CVRM: n= 9) and Chronic 
Obstructive Pulmonary Disease (COPD: n= 4), prospectively monitored over a two-
year period. MethOds: Performance scores were grouped according to the triple 
aim framework for the three aims of integrated care: 1) improving population health 
outcomes, 2) improving patient experience and 3) reducing costs. Included indi-
cators were the EuroQol-5D, Short-Form-36, smoking and physical activity levels, 
the PACIC (Patient Assessment of Chronic Illness Care) and various cost measure-
ments. Estimation was done by means of the average predicted outcomes from a 
generalised linear model. To increase comparability between programs a multi-
nomial generalisation of propensity score matching (PSM) was applied. Results: 
Differences between the estimated treatment effects were expected based on the 
comprehensiveness of their interventions, e.g. estimated smoking rate was 28% in 
our most comprehensive COPD program, compared to 38% in our least significant 
program. PSM influenced the results, especially for costs and to a lesser extent 
for different dimensions of the EuroQol-5D. Overall, CVRM programs were more 
susceptible to changes resulting from PSM, which may be attributed to the higher 
number of programs. cOnclusiOns: The proposed econometric methods offer a 
novel way to estimate performance scores from outcomes data in disease manage-
ment programs. The estimated performance matrix offers useful distinctiveness 
between criteria and programs as an input for follow-up studies which further 
explore the performance matrix or attach relative weights to each performance 
indicator to allow a formal MCDA.
PRM204
telePhone veRsus face-to-face inteRvieWs foR Patient-RePoRteD 
outcoMe instRuMent DeveloPMent
Mazar I, Lamoureux R, Ojo O, Kevane G, Banderas B, Stokes J, Shields A
Adelphi Values USA, Boston, MA, USA
Objectives: This study provides clinical researchers with guidance for determin-
ing the appropriateness of telephone versus face-to-face (F2F) interview methods 
when conducting patient-centered qualitative research to inform instrument devel-
opment for use in regulated clinical trials. MethOds: The benefits and limita-
tions of telephone versus F2F interviews were identified from the peer-reviewed 
literature (N= 15 studies) and discussed in the context of our own experiences 
conducting approximately 90 qualitative patient interview studies in the past five 
years. Results: Evidence suggests a variety of convenience benefits associated 
with telephone interviews (e.g., cost, access to patients) and that, overall, while 
some information is sacrificed (e.g., non-verbal communications), little to no data 
quality is lost when conducting interviews via telephone versus in-person. However, 
experience suggests instances in which data quality between telephone and F2F 
interviews can vary dependent on purpose of interview and target patient popula-
tion. With respect to the purpose of the interview, telephone methods lend them-
selves best for concept elicitation, while in-person methods may be more suitable 
for cognitive debriefing, mode of administration equivalency, and usability testing. 
With regard to target patient population, telephone methods may be appropriate for 
less vulnerable patient populations and/or well-defined disease areas, but less so for 
extremely sick or physically or emotionally compromised patients. cOnclusiOns: 
Researchers developing instruments for use in regulated trials can consider tel-
ephone interviews viable for capturing qualitative patient data; however, the meth-
od’s suitability varies depending on the purpose of the interviews and the target 
patient population. Additionally, some of the perceived “convenience” benefits of 
telephone interviews may not be fully realized when weighed against some surpris-
ing challenges inherent to their conduct including family members’ presence during 
interviews and frequent tardiness. Practical guidance for the selection of interview 
mode is provided and solutions to address practical challenges associated with 
phone interviews are discussed.
ReseaRch on MethoDs – statistical Methods
PRM205
inteRPReting Results fRoM bayesian netWoRk Meta-analyses (nMa): a 
guiDe foR non-statisticians
Pacou M1, Taieb V2, Belhadi D2, Mesana L3, Gauthier A2
1Amaris, Paris, France, 2Amaris, London, UK, 3Amaris London, London, UK
Objectives: Bayesian NMAs enable us to report results based on probabilities, 
treatment ranking and predictions and are increasingly used to support decision-
making in HTAs. However, there is a lack of guidance on how to report and inter-
pret results from Bayesian analyses. In addition, the complexity of this type of 
analyses makes these findings difficult to understand by analysts not trained in 
Bayesian statistics. We aim to define in simple terms the key concepts behind 
Bayesian methodology and present a guide to help non-statisticians understand 
and interpret findings from Bayesian NMAs. MethOds: Majorguidelines (incl. 
Some items influenced by DIF might be another potential problem. Further studies 
on item effects are needed in reporting quality of life.
PRM200
eMPiRical eviDence foR iDentifying best PRactices in tRanslatability 
assessMent as a PRoactive tool foR enhancing the quality of PRo 
anD hRqol tRanslation anD linguistic valiDation
Tyupa S1, Wild D2
1Jagiellonian University in Kraków, Krakow, Poland, 2Parkinsons UK, Oxford, UK
Objectives: The essence of translatability assessment (TA) is to identify potential 
translation problems before the linguistic validation process of PRO and HRQoL 
measures begins; this means that any issues can be resolved prior to the beginning 
of the translation which will improve the quality of the translation, the harmoniza-
tion between language versions and the cultural validity of the measure. It is an 
important step in the development of new measures but there is a lack of guidance 
on the optimal methodology including the number of and experience levels of 
linguists and that need to be involved in the TA itself. The objective of the present 
study was to establish the optimal number of linguists required in a TA process and 
to qualitatively explore any differences based on experience levels. MethOds: A 
study was carried out, which involved 18 translators, all native speakers of Polish 
and proficient in English, who individually completed a TA of a schizophrenia-
specific measure (SQLS-R4) where they were presented with the items and response 
options and asked to comment on their translatability into Polish. Results: The 
results show extreme variation in the number and nature of problems identified 
between translators. For example, some translators made 2 comments for the total 
of 40 items presented for assessment, whereas others made over 15 comments. An 
assessment of the number and nature of the comments in relation to the experience 
of the translators suggest that those translators with more experience were able to 
provide more detail around their concerns. This provides strong evidence for the 
claim that differences in TA may be caused not by actual linguistic issues but by 
idiosyncrasies of individual translators. cOnclusiOns: Based on the results, it is 
suggested to involve at least two translators per given language for TA.
PRM201
soMething olD, soMething boRRoWeD, soMething neW: a DiRect 
coMPaRison of thRee qualitative elicitation MethoDs
Kitchen H1, Willgoss TG1, Meysner S1, Trigg A1, Dickinson S2, Humphrey L1
1Abacus International, Manchester, UK, 2National Ankylosing Spondylitis Society, London, UK
Objectives: Innovative approaches in patient-reported outcomes (PRO) research 
are widely sought. Yet no published research has prospectively compared traditional 
methods for gathering patient insight with novel methods. In this groundbreaking 
study, aimed at identifying patient-reported symptoms of Ankylosing Spondylitis 
(AS), we explored the value of traditional interview methods against social media 
methods and Group Concept Mapping (GCM). MethOds: Three methodologies 
were utilized: 1. Open-ended interviews; 2. online AS patient forums; 3. GCM. 
Participants with AS were recruited from National Ankylosing Spondylitis Society 
(NASS). Interviews and social media data were analysed using ATLAS.ti. GCM was 
conducted on Concept Systems Global MAX software, utilizing multivariate and 
cluster analysis. Analysis for each methodology was performed by an independent 
researcher to ensure impartiality. Three conceptual models of AS symptoms were 
developed based on data from each methodology. Results: Participants completed 
interviews (n= 12) or a GCM exercise (n= 20). Of 14 social media sources identified, 
two met pre-defined criteria; 100 posts were analysed. From a scientific perspective, 
the conceptual models derived from each methodology were broadly compara-
ble supporting the use of novel approaches (in addition to traditional methods) to 
generate patient insights – variations in the conceptual models (and the reasons 
why) will be presented. From a practical perspective, time and cost are substan-
tive when interviewing but are significantly less when using social media data 
or GCM. Furthermore, the ability to perform robust quantitative analysis in GCM 
is particularly advantageous. cOnclusiOns: Methodological advancement is key 
to progress in outcomes research. Without advancing new methods, we cannot 
develop as a field of scientific inquiry. Typically, researchers intimate the relative 
benefits of one method over another. However, in this first study to prospectively 
compare novel with traditional PRO methods, we demonstrated the added value 
of two new approaches and laid bare the scientific and practical considerations for 
qualitative PRO research design.
PRM202
anchoRing bias in tto valuations
Garcia-Molina M, Chicaiza  Becerra LA
Universidad Nacional de Colombia, Bogota, Colombia
Objectives: Time trade-off (TTO) is one of the main methodologies for eliciting 
health-states utilities in order to determine values. There are large differences in 
implementation methods and results. Anchoring is a cognitive bias that arises 
when answers to a question are attracted by otherwise irrelevant information. 
Anchoring was found in Lead-time TTO as lead times attracted valuations. This 
study enquiries whether the starting point in the TTO iteration procedure induces 
anchoring. MethOds: 89 economics students aged 18 to 25 valued five EQ-5D 
health states using TTO. The horizon was 40 years, so that the results were close to 
their life expectancy. The respondents were randomly allocated to two groups. For 
the first group, the first question compared 40 years in perfect health to 40 years 
in the valued health state. For the second group, the first question compared 20 
years in perfect health to 40 years in the valued health state. Then it went up or 
down depending on the answer. Anchoring was expected to appear in the form of 
higher valuations for the group starting from 40 than for the group starting from 20. 
Only states better than death were considered. Worse than death valuations were 
excluded from the health-state sample. Results: The mean valuation for the 40 
groups was higher than for the 20 group for each health state. The difference in 
means was significant at 5% for three health states and at 10% for another one. It 
